Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetes.
Saved in:
| Title: | Exposure-response analysis for evaluation of semaglutide dose levels in type 2 diabetes. |
|---|---|
| Authors: | Petri KCC; Department of Quantitative Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark., Ingwersen SH; Department of Quantitative Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark., Flint A; Department of Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark., Zacho J; Department of Semaglutide Medical and Science, Global Development, Novo Nordisk A/S, Søborg, Denmark., Overgaard RV; Department of Quantitative Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Sep; Vol. 20 (9), pp. 2238-2245. Date of Electronic Publication: 2018 Jun 15. |
| Publication Type: | Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
